FTNT vs LAB · P/E 56, rev $6.80B vs rev $174.4M
Fortinet Inc (FTNT) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Fortinet Inc (FTNT) is a software - infrastructure company listed on NASDAQ.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported FTNT revenue for 2025-12-31 was $6.80B. Net income was $1.85B. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
FTNT currently screens at market cap $105.60B and trailing P/E 56.1. LAB currently screens at market cap $317.1M.
Not investment advice. Open the FTNT and LAB stock pages for the full models.
Not investment advice.